rs115515098
Variant names:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_004792.3(PPIG):c.1485A>G(p.Glu495Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0025 in 1,612,472 control chromosomes in the GnomAD database, including 88 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0038 ( 10 hom., cov: 32)
Exomes 𝑓: 0.0024 ( 78 hom. )
Consequence
PPIG
NM_004792.3 synonymous
NM_004792.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0870
Genes affected
PPIG (HGNC:14650): (peptidylprolyl isomerase G) Enables cyclosporin A binding activity and peptidyl-prolyl cis-trans isomerase activity. Involved in protein peptidyl-prolyl isomerization. Located in cytosol and nuclear speck. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 2-169636743-A-G is Benign according to our data. Variant chr2-169636743-A-G is described in ClinVar as [Benign]. Clinvar id is 785854.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.087 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.00383 (583/152242) while in subpopulation AMR AF= 0.0254 (387/15266). AF 95% confidence interval is 0.0233. There are 10 homozygotes in gnomad4. There are 308 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 583 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PPIG | NM_004792.3 | c.1485A>G | p.Glu495Glu | synonymous_variant | Exon 14 of 14 | ENST00000260970.8 | NP_004783.2 | |
PPIG | XM_005246966.3 | c.1485A>G | p.Glu495Glu | synonymous_variant | Exon 14 of 14 | XP_005247023.1 | ||
PPIG | XM_005246967.2 | c.1485A>G | p.Glu495Glu | synonymous_variant | Exon 14 of 14 | XP_005247024.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00382 AC: 581AN: 152124Hom.: 10 Cov.: 32
GnomAD3 genomes
AF:
AC:
581
AN:
152124
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00782 AC: 1920AN: 245368Hom.: 41 AF XY: 0.00644 AC XY: 861AN XY: 133614
GnomAD3 exomes
AF:
AC:
1920
AN:
245368
Hom.:
AF XY:
AC XY:
861
AN XY:
133614
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00236 AC: 3448AN: 1460230Hom.: 78 Cov.: 36 AF XY: 0.00220 AC XY: 1601AN XY: 726376
GnomAD4 exome
AF:
AC:
3448
AN:
1460230
Hom.:
Cov.:
36
AF XY:
AC XY:
1601
AN XY:
726376
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00383 AC: 583AN: 152242Hom.: 10 Cov.: 32 AF XY: 0.00414 AC XY: 308AN XY: 74464
GnomAD4 genome
AF:
AC:
583
AN:
152242
Hom.:
Cov.:
32
AF XY:
AC XY:
308
AN XY:
74464
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
45
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
May 17, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at